AUDREY GUENICHE

Dr. AUDREY GUENICHE


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2010 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
AGAUDREY GUENICHE
AUDREY GUENICHE
PBPhilippe Bastien
Philippe Bastien
JOJean Marc Ovigne
Jean Marc Ovigne
MKMichel Kermici
Michel Kermici
GCGuy Courchay
Guy Courchay
ICIsabelle Castiel‐Higounenc
Isabelle Castiel‐Higounenc

13 October 2017 in Beneficial Microbes
Verified
Journal Article
Open access
PRP. Reygagne
P. Reygagne
PBPhilippe Bastien
Philippe Bastien
MCM.P. Couavoux
M.P. Couavoux
DPD. Philippe
D. Philippe
MRM. Renouf
M. Renouf
AGAUDREY GUENICHE
AUDREY GUENICHE
Dandruff is a common persistent, relapsing inflammatory condition affecting the scalp. An imbalanced proportion of the major bacterial and fungal populations colonising the scalp, a skin barrier dysfunction, and hyperseborrhoea are three main etiological factors of dandruff. The efficacy ofLactobacillus paracaseiNCC 2461 ST11 (ST11) to manage dandruff and to restore a balanced scalp microbiome was assessed. Sixty healthy male volunteers aged 18 to 60 years with moderate to severe dandruff consumed on a daily basis a sachet containing ST11 (1×109cfu) or a placebo for 56 days. Clinical efficacy (free and adherent dandruff, erythema, scalp seborrhoea, global clinical score), subject self-assessments, safety reporting as well as scalp microbiota assessments were performed every two weeks (day 1, 15, 29, 43, 57 and 64/follow-up). Free and adherent dandruff, erythema and the global clinical score improved significantly (allP<0.05) over time in the ST11 group and as compared to the placebo when day 57 was compared to day 1. Self-assessments paralleled these findings. ST11 enhanced restoring the scalp microbiota after 56 days of supplementation when compared to the placebo. No adverse events were reported. Regular intake of ST11 over 56 days is safe and reduces significantly the severity of signs and symptoms of moderate to severe dandruff. Its efficacy is potentially due to its positive impact on the skin barrier and skin immune system.

1 September 2009 in Dermato-Endocrinology
Verified
Journal Article
Closed access
AGAUDREY GUENICHE
AUDREY GUENICHE
PDPhilippe David
Philippe David
BPBatien Philippe
Batien Philippe
BSBlum Stephanie
Blum Stephanie
BEBuyukpamukcu Elif
Buyukpamukcu Elif
CICastiel-Higounenc Isabelle
Castiel-Higounenc Isabelle
Specific strains of probiotic lactic acid bacteria, have been shown to beneficially influence the composition and/or metabolic activity of the endogenous microbiota and some of these strains have been shown to inhibit the growth of a wide range of enteropathogens. The first aim of using probiotics has been to improve the composition of the intestinal microbiota from a potentially harmful composition towards a composition that would be beneficial to the host Beyond their capacity to influence positively the composition of the intestinal microbiota, several lines of evidence suggest that some probiotic bacteria can modulate the immune system both at the local and systemic levels thereby improving immune defense mechanisms and/or down-regulate immune disorders such as allergies or intestinal inflammation. Skin reflects the general health status and aging. Different human trials widely suggest that probiotic supplementation might be useful in the management of atopic dermatitis. Based on these properties it appears that, beyond the gut, probiotics might exert their benefit at the skin level. In a randomized double blind placebo-controlled clinical trial, we investigated whether the probiotic bacteria Lactobacillus johnsonii NCC 533 (La1) could modulate the cutaneous immune homeostasis altered after solar-simulated UV exposure in humans. After, UV exposure to twice 1.5 MED, we demonstrated that La1 intake facilitated an earlier recovery of EC allostimulatory function. Thus, this clinical data strengthen the assumption that certain probiotics can contribute to modulate skin immune system leading to the preservation of the skin homeostasis. Altogether the data affords the possibility of designing new strategies based on a nutritional approach for the prevention of UV-induced damaging effects.

22 October 2010
Verified
Journal Article
Closed access
AGAUDREY GUENICHE
AUDREY GUENICHE
JBJalil Benyacoub
Jalil Benyacoub
DPDavid Philippe
David Philippe
PBPhilippe Bastien
Philippe Bastien
NKNicole Kusy
Nicole Kusy
ICIsabelle Castiel-Higounenc
Isabelle Castiel-Higounenc
Over the past few decades the number of people presenting reactive skin has increased in industrial countries. Skin inflammation mediated by neuropeptides and impaired skin barrier function are both underlying features of reactive skin conditions. Live microorganisms defined as probiotics have been successfully used to improve health status in humans. Beyond the effects on intestinal microbiota, some probiotic strains display potent immune-modulatory properties at the skin level. The aim of this study was to evaluate whether Lactobacillus paracasei CNCM-I 2116 (ST11) could modulate reactive skin-associated inflammatory mechanisms. The Caco-2/PBMC co-culture cell system was stimulated on the apical side with probiotics. The resulting medium collected from the basolateral compartment of the cell culture system, so called conditioned medium, was tested in ex vivo human abdominal plastic skin explant models of substance P-induced skin inflammation and skin barrier reconstruction. We show that ST11 was able to abrogate vasodilation, edema, mast cell degranulation and TNF-alpha release induced by substance P, compared to control. Moreover, using ex vivo skin organ culture, we show that ST11-conditioned medium induced a significantly faster barrier function recovery after SLS disruption, compared to control. These results support a beneficial role of ST11 on key biological processes associated with barrier function and skin reactivity.

14 July 2008 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
AGAUDREY GUENICHE
AUDREY GUENICHE
ACA‐C Cathelineau
A‐C Cathelineau
PBPhilippe Bastien
Philippe Bastien
JEJ Esdaile
J Esdaile
RMR Martin
R Martin
LBL Breton
L Breton

1 August 2015 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
AAAmine Achachi
Amine Achachi
MVMarc Vocanson
Marc Vocanson
PBPhilippe Bastien
Philippe Bastien
JPJosette Péguet-Navarro
Josette Péguet-Navarro
SGSophie Grande
Sophie Grande
AGAUDREY GUENICHE
AUDREY GUENICHE